<PAGE>

                                  EXHIBIT 10.5
                           PLACEMENT AGENT'S AGREEMENT

                                                                  March 11, 2004

                                                                  VIA TELECOPIER
                                                                    305-932-4404

Mr. David A. Collins, President
DAC Technologies Group International, Inc.
1601 Westpark Drive, Suite 4C
Little Rock, AR  72204

Dear Mr. Collins:

      In connection with Keane Securities Co., Inc. (the "Placement Agent" or
"Keane") acting as the exclusive agent and representative with respect to the
private placement (the "Placement") of certain securities (the "Units") of DAC
Technologies Group International, Inc. (the "Company"), described on the term
sheet ("Term Sheet") attached hereto as Exhibit A, the provisions of which shall
be incorporated herein as if at length set forth, the Company and the Placement
Agent hereby agree as follows:

      1.    The Company hereby agrees to pay and deliver to the Placement Agent
at the closing(s) the compensation set forth in Exhibit A for the Placement
Agent's services. The foregoing compensation shall be deemed earned and shall be
due and payable only upon consummation of the closing and in no event shall such
compensation (except for reimbursable expenses) be deemed earned nor be payable
if the closing(s) do not occur.

      2.    The Placement Agent acknowledges that the Units will not have been
registered under the Securities Act of 1933, as amended, (the "Act") or any
state

                                       1
<PAGE>

securities laws in reliance upon existing exemptions for private offerings and
that neither the Units nor the components thereof can be sold unless they are
registered or an exemption from registration is available.

      3.    The Company and the Placement Agent each represent to the other that
it has not taken, and the Company and the Placement Agent each agree with the
other that it will not take any action, directly or indirectly, so as to cause
the Placement to fail to be entitled to rely upon the exemption from
registration afforded by Section 4(2) of the Act and Regulation D promulgated
thereunder. In effecting the Placement, the Company and the Placement Agent each
agree to comply in all material respects with all applicable provisions of the
Act and any regulations thereunder and all applicable state laws and
requirements. It is understood by the Company and the Placement Agent that the
investors in the Placement will be "accredited investors" within the meaning of
Regulation D, and that all investors shall be subject to the approval of the
Company and the Placement Agent in all events.

      4.    The Placement Agent shall use diligent efforts to complete the
Placement as contemplated herein by June 15, 2004. If the minimum Placement
closes by June 15, 2004, the Placement Agent shall have until July 15, 2004 to
complete the maximum Placement. The Company agrees that from the date hereof
through June 15, 2004, it shall not attempt to sell any of its securities except
through the Placement Agent. At the closing, the Company shall deliver
covenants, warranties, representations and opinions as are traditional in
private placements.

      5.    The Company understands and agrees that Keane, in performing its
services hereunder, will use and rely upon the information contained in certain
documents ("Placement Documents") to be prepared by the Company and upon other
information supplied by the Company, and that Keane does not assume
responsibility for independent verification of any information concerning the
Company, including, without limitation, any financial information, forecasts or
projections considered by Keane in connection with the rendering of its
services. Accordingly, Keane shall be entitled to assume and rely upon the
accuracy or completeness of all such information, and is not required to conduct
a physical inspection of any of the properties or assets or to prepare or obtain
any independent evaluation or appraisal of any of the assets or liabilities of
the Company. With respect to any financial forecasts and projections made
available to Keane by the Company and used by Keane in its analysis, Keane shall
be entitled to assume that such forecasts and projections have been prepared on
reasonable bases reflecting the best currently available estimates and judgments
of the management of the Company as to the matters covered thereby. While Keane
can rely on such information, it reserves the right to investigate, confirm
and/or request other

                                       2
<PAGE>

information in conjunction with the Company, or independently, and the Company
will cooperate in providing such information and/or instructing its outside
counsel and auditors to supply such information.

      6.    The Company authorizes Keane, as the Company's exclusive Placement
Agent, to submit the Placement Documents to potential investors and to execute
on behalf of the Company if, as and when necessary a customary confidentiality
agreement to be entered into by such parties. Additionally, the Company
authorizes Keane to take all reasonable actions necessary to perform its
services on behalf of the Company as exclusive Placement Agent as long as such
actions are in accordance with this Agreement.

      7.    The Company covenants that for a period of one (1) year from the
closing of the Placement, Keane shall have the right to purchase for Keane's
account or to sell for the account of the Company any securities (other than
purely debt securities; securities offered as part of a compensation plan for
officers, employees and consultants; and securities offered in exchange for
assets or securities of other corporations) with respect to which the Company
may seek a public offering in the United States pursuant to a registration under
the Act and/or a private offering in the United States of said securities. The
Company will consult Keane with regard to any such offering and will offer Keane
exclusively the opportunity to purchase, sell or act as underwriter or placement
agent for the purchase or sale of any such securities on terms not less
favorable to the Company than it can secure elsewhere. If Keane fails to accept
in writing such proposal for financing made by the Company within ten (10)
business days after the receipt of a notice containing such proposal, then Keane
shall have no further claim or right with respect to the financing proposal
contained in such notice. If, thereafter, such proposal is modified in any
material respect, the Company shall adopt the same procedure as with respect to
the original proposal. If Keane does not avail itself of such opportunity to act
as underwriter or placement agent, this will not affect its preferential rights
for future financings during the aforesaid one (1) year period. The Company
acknowledges that its violation of the covenants of this Paragraph 7 and/or
violation of Keane's rights of first refusal would cause irreparable harm to
Keane and agrees that Keane shall be entitled to injunctive relief to prevent
any violation of the provisions of this Paragraph 7. The Company represents and
warrants that no other person or

                                       3
<PAGE>

entity has any rights to participate in any offer, sale or distribution of
securities with respect to which Keane shall have preferential rights. The
Company also represents and warrants that the terms contemplated herein will not
breach any covenant warranty or condition agreed to by the Company in the equity
and/or debt financings effected by the Company to date. Keane may exercise the
right of first refusal granted pursuant to this Paragraph 7 either on its own
behalf or together with another firm or firms designated by Keane and reasonably
acceptable to the Company, provided, that in each instance Keane shall be fully
qualified to act as underwriter or placement agent in the offering.

      8.    The Company hereby agrees to indemnify and hold harmless the
Placement Agent and its officers, directors and shareholders, individually and
collectively, ("Indemnified Person(s)") from and against any and all claims,
liabilities, losses, damages and reasonable expenses incurred by any Indemnified
Person (including reasonable fees and disbursements of one law firm) which (a)
are related to or arise out of (i) actions taken or omitted to be taken
(including any untrue statements made or any statements omitted to be made) by
the Company or (ii) actions taken or omitted by an Indemnified Person with the
Company's written consent or in conformity with the Company's prior written
instructions or (b) are otherwise directly related to or arise out of the
Placement, and will reimburse the Indemnified Persons for all reasonable costs
or expenses, including reasonable fees and disbursements of counsel, as they are
incurred, in connection with an investigation, inquiry or other proceeding,
whether or not in connection with pending or threatened litigation, caused by or
arising out of or in connection with the Placement whether or not any liability
results therefrom. The Company will not, however, be responsible for any claims,
liabilities, losses, damages, or expenses which are finally judicially
determined to have resulted primarily from the Placement Agent's bad faith,
gross negligence or willful misconduct.

      The Placement Agent hereby agrees to indemnify and hold harmless the
Company and its officers, directors and shareholders, individually and
collectively, ("Indemnified Person(s)") from and against any and all claims,
liabilities, losses, damages and reasonable expenses incurred by any Indemnified
Person (including reasonable fees and disbursements of one law firm) which (a)
are related to or arise out of (i) actions taken or omitted to be taken
(including any untrue statements made or any statements omitted to be made) by
the Placement Agent or (ii) actions taken

                                       4
<PAGE>

or omitted by an Indemnified Person with the Placement Agent's written consent
or in conformity with the Placement Agent's prior written instructions or (b)
are otherwise directly related to or arise out of the Placement, and will
reimburse the Indemnified Persons for all reasonable costs or expenses,
including reasonable fees and disbursements of counsel, as they are incurred, in
connection with an investigation, inquiry or other proceeding, whether or not in
connection with pending or threatened litigation, caused by or arising out of or
in connection with the Placement whether or not any liability results therefrom.
The Placement Agent will not, however, be responsible for any claims,
liabilities, losses, damages, or expenses which are finally judicially
determined to have resulted primarily from the Company's bad faith, gross
negligence or willful misconduct.

      9.    In the event of a closing of the Placement, Keane shall have the
right to disclose its participation therein, including, without limitation, the
placement of "tombstone" advertisements in financial and other newspapers and
journals as an accountable expense (maximum $7,500) provided for in Exhibit A,
subject to the prior review of and approval by counsel to the Company.

      10.   The Company recognizes that Keane has been engaged by the Company
only and that the Company's engagement of Keane is not deemed to be on behalf of
and is not intended to confer rights upon any shareholder, partner or other
owner of the Company or any other person not a party hereto as against Keane or
its directors, officers, agents, employees or representatives. Unless otherwise
expressly agreed, no one other than the Company is authorized to rely upon the
Company's engagement of Keane or any statements, advice, opinions or conduct by
Keane. Without limiting the foregoing, any opinions or advice rendered by Keane
to the Company's Board of Directors or management in the course of the Company's
engagement of Keane are for the purpose of assisting the Board or management, as
the case may be, in connection with the Placement and do not constitute a
recommendation to any shareholder of the Company, concerning action that such
shareholder might or should take in connection with the Placement. Keane's role
herein is that of an independent contractor, nothing herein is intended to
create or shall be construed as creating a fiduciary relationship between the
Company and Keane.

                                       5
<PAGE>

      11.   All notices, requests or instructions hereunder shall be in writing
and delivered personally, sent by telecopier or sent by registered or certified
mail, postage prepaid, as follows:

                        (1)   If to the Company:
                                    DAC Technologies Group International, Inc.
                                    1601 Westpark Drive, Ste. 4C
                                    Little Rock, AR 72204
                                    Att: David A. Collins, President
                                    Telecopier: 305-932-4404

                        (2)   If to the Placement Agent:
                                    Keane Securities Co., Inc.
                                    50 Broadway, 13th Floor
                                    New York, New York 10004
                                    Att: Walter D. O'Hearn, Jr.,
                                    Senior Vice President
                                    Telecopier: 212-509-6613

      Any of the above addresses may be changed at any time by notice given as
set forth above; provided, however, that any such notice of change of address
shall be effective only upon receipt. All notices, requests or instructions
given in accordance herewith shall be deemed received on the date of delivery,
if hand delivered or delivered by telecopier and two (2) business days after the
date of mailing, if mailed.

      12.   Except as expressly set forth herein, this Agreement, Exhibit A and
the Agent's Warrants contain the entire agreement among the parties hereto with
respect to the transaction contemplated hereby and shall supersede all previous
agreements of the parties with respect to the subject matter thereof.

      13.   This Agreement shall not be assignable by either party hereto except
pursuant to a writing executed by all of the parties hereto. This Agreement
shall be binding upon and inure to the benefit of the parties hereto and their
respective successors and permitted assigns.

      14.   If any provision of this Agreement, or the application of any such
provision to any person or circumstance, shall be held invalid by a court of
competent jurisdiction, the remainder of this Agreement, or the application of
such

                                       6
<PAGE>

provision to persons or circumstances other than those as to which it is held
invalid, shall not be affected thereby.

      15.   In addition to the covenants and agreements herein above provided,
each of the parties hereto shall use such party's diligent efforts to take such
actions as may be reasonably necessary or reasonably requested by the other
party hereto to carry out and consummate the transactions contemplated by this
Agreement.

      16.   This Agreement may be executed in counterparts, each of which shall
be deemed an original, but all of which taken together shall constitute one and
the same instrument.

      17.   No modification or amendment of this Agreement shall be effective
unless in writing and signed by the party against which it is sought to be
enforced.

      18.   This Agreement shall be governed by and construed in accordance with
the laws of the State of New York.

                                             Very truly yours,

                                             Keane Securities Co., Inc.

                                             By:/s/ Walter D. O'Hearn, Jr.
                                             Title: Senior Vice President

Agreed:

DAC Technologies Group International, Inc.

By: /s/ David A. Collins
Title:  President

                                       7
<PAGE>

EXHIBIT A

TO:        DAC Technologies Group International, Inc. (the "Company")

FROM:      Keane Securities Co., Inc. ("Placement Agent" or "Keane")

RE:        THE PLACEMENT

                                   TERM SHEET

PRINCIPAL AMOUNT - $1.7 million with a minimum of $500,000 and a minimum
investment of $25,000 per investor (unless waived by the Company and the
Placement Agent.)

THE UNITS: a) Up to Sixty eight (68) Units priced at $25,000 per Unit with each
Unit to consist of:

            - An undetermined number of shares of the Company's common stock par
value $ _____ per share (the "Common Stock") as equals $25,000 divided by the
Closing Price of the Common Stock as hereinafter defined.

            - The number of Common Stock purchase warrants (the "Unit Warrants")
            as will produce a 50% warrant coverage. By way of example, assuming
            the Closing Price of Common Stock is pegged at $2.00 per share, each
            $25,000 Unit will consist of 12,500 shares of Common Stock and 6,250
            Unit Warrants.

            b) Each Unit Warrant shall entitle the holder to purchase one (1)
      share of Common Stock for the greater of $2.40 or 150% of the Closing
      Price of the Common Stock (as hereinafter defined) per share for a period
      of five (5) years from the date of issue. Each Unit Warrant shall contain
      customary anti-dilution provisions. By way of example, assuming the
      Closing Price of the Common Stock is pegged at $2.00 per share, each Unit
      Warrant will be exercisable at $3.00 per share.

                                       8
<PAGE>

            c) The term Closing Price of the Common Stock shall mean the average
      of the daily closing prices (or closing bid price if there is no closing
      price) of the Common Stock for a period of ten (10) trading days ending
      two (2) trading days prior to the closing date but in no event less than
      $1.60.

            d) The Unit Warrants shall be non-redeemable for a period of two (2)
      years from the date of the closing of the Placement. Unit Warrants shall
      be redeemable, in whole and not in part, at the option of the Company,
      upon thirty (30) days prior written notice at a redemption price of $.05
      per Warrant from and after that time when the Closing Price of the Common
      Stock (as defined) for each of ten (10) consecutive trading days ending
      not less than five (5) days before the date of the aforesaid redemption
      notice exceeds 200% of the Closing Price of the Common Stock.

PLACEMENT AGENT'S FEE - 8% of the aggregate proceeds from all sales of the Units
achieved through the efforts of the Company, Keane and/or any third party, paid
at closing(s).

            - 5,000 warrants, identical to the Unit Warrants, issued to Keane
            and/or its designees for each Unit sold (at a cost of $.001 per
            warrant) (the "Agent's Warrants").

            - Accountable, reimbursable expenses, including legal fees, not to
            exceed $30,000 with a non-refundable advance of $5,000.

ADDITIONAL TERMS AND CONDITIONS:

      a) Placement Documents to be satisfactory in form and content:

            1.    A detailed statement of the intended use of net proceeds and
                  detailed two (2) year projections with a statement of
                  assumptions.

                                       9
<PAGE>

            2.    A Subscription Agreement containing standard covenants,
                  representations, warranties and conventional anti-dilution
                  protections.

            3.    A Registration Rights Agreement providing for 1) immediate
                  registration of the Common Stock underlying the Units and Unit
                  Warrants on Form S-3 if the Company is eligible to use such
                  Form or 2) registration of said Common Stock as soon as the
                  Company becomes eligible to use Form S-3, and also providing
                  for evergreen piggyback rights in the event the Company is not
                  eligible to use Form S-3; all at the expense of the Company.

            4.    Form 10k for the year ended December 31, 2003.

            5.    An Accredited Investor Questionnaire apart from or as a part
                  of the Subscription Agreement.

            6.    A list of directors, officers and 5% or greater shareholders
                  by name, residence address, social security number and
                  relationship with the Company.

            7.    ALL material written agreements.

            8.    The latest filed U.S. tax return.

      b)    For a three (3) year period from the first closing, the Company
            shall grant Keane the right to appoint a designee as an observer
            having the right to attend all meetings of the Company's Board of
            Directors and Committees but not having the right to vote. The
            observer will be reimbursed for his out-of-pocket expenses in
            connection with attending such meetings.

      c)    If the Company closes a sale(s) of any of its securities within
            twenty four (24) months after the first closing of the Placement
            with any of the investors introduced by Keane to the Company in
            writing, Keane shall be entitled to the cash portion of Placement
            Agent's Fee and Agent's Warrants set forth above. This provision
            shall not be deemed to alter the one (1) year preferential rights
            period provided for in Section 7 of this Agreement.

                                       10
<PAGE>

      d)    Escrow Agreement: The Placement Agent will promptly deposit funds
            received from investors in an escrow account or other account (the
            "Account") permitted by Rule 15c2-4 promulgated under the Securities
            and Exchange Act of 1934, as amended, formed by the Placement Agent
            with a qualified institution (the "Bank") and hold funds in
            accordance with the terms of this Agreement for the benefit of the
            investors and Company. The Bank shall release funds from the Account
            to the Company and/or its designees only upon receipt of
            instructions executed by each of the Placement Agent and the
            Company. If the Placement does not close on or before May 15, 2004,
            the Placement Agent will instruct the Bank to return the funds to
            the investors without any deduction therefrom or interest thereon.
            The Company shall bear the costs of the escrow account.

      e)    Conditions to closing: No closing of this Placement shall take place
            unless, prior to June 15, 2004, the Company shall have caused its
            counsel to issue an opinion in form and content reasonably
            satisfactory to Keane; it being understood that said opinion must
            set forth a Rule 10b-5 statement.

      f)    Closing: The closing(s) of the Placement shall take place at the
            offices of the Company or the Placement Agent at times and dates
            agreed upon by the Placement Agent and the Company upon the receipt
            of Subscription Agreements and related documents in form and
            substance satisfactory to the Company and the Placement Agent which
            are equal to or are in excess of the Placement. At each closing,
            payment for the Units shall be made against delivery of certificates
            representing the Units sold.

                                       11